El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 

Mapping iron content and white matter integrity in the anterior thalamic radiations across Huntington's disease stages

dc.contributor.authorDomingo Ayllón, Montserrat
dc.contributor.authorGarcía-Gorro, Clara
dc.contributor.authorRodríguez Dechichá, Nadia
dc.contributor.authorVaquer, Irene
dc.contributor.authorCalopa, Matilde
dc.contributor.authorDiego Balaguer, Ruth de
dc.contributor.authorCamara Mancha, Estela
dc.date.accessioned2025-09-19T11:50:21Z
dc.date.available2025-09-19T11:50:21Z
dc.date.issued2025-01-01
dc.date.updated2025-09-19T11:50:21Z
dc.description.abstractHuntington’s disease (HD) is characterized by progressive neurodegeneration, often accompanied by disrupted iron regulation and altered white matter (WM) integrity. This study investigates iron content and microstructural changes in the anterior thalamic radiations (ATR) across different HD stages. Thirty-one gene carriers and twenty-four controls underwent neuropsychological assessment and 3 T-MRI scanning, including relaxometry and diffusion tensor imaging (DTI) sequences to assess iron content and WM microstructure. ATR changes were examined using average and along-the-tract analyses, with ANOVA and post-hoc Tukey tests to identify group differences and Spearman correlations to evaluate clinical associations. Machine-learning models were applied to assess the potential of MRI metrics as diagnostic biomarkers for HD, focusing on disease stage differentiation and presymptomatic detection. Premanifest individuals exhibited increased iron content and enhanced WM integrity bilaterally, while manifest patients maintained elevated left ATR iron levels alongside bilateral WM degeneration. Both ATRs contribute to the clinical manifestations of HD, including cognitive impairment and neuropsychiatric disturbances. Both along-the-tract relaxometry and DTI metrics emerged as promising biomarkers for distinguishing HD subgroups and identifying presymptomatic individuals. These findings highlight the interplay between iron dysregulation and WM disruption in HD, offering potential pathways for early diagnosis and targeted therapeutic strategies.
dc.format.extent16 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec760628
dc.identifier.issn2213-1582
dc.identifier.pmid40858070
dc.identifier.urihttps://hdl.handle.net/2445/223293
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.nicl.2025.103866
dc.relation.ispartofNeuroimage-Clinical, 2025, vol. 48, 103866
dc.relation.urihttps://doi.org/10.1016/j.nicl.2025.103866
dc.rightscc-by-nc-nd (c) Domingo Ayllón, Montserrat, et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceArticles publicats en revistes (Cognició, Desenvolupament i Psicologia de l'Educació)
dc.subject.classificationCorea de Huntington
dc.subject.classificationMapatge del cervell
dc.subject.otherHuntington's chorea
dc.subject.otherBrain mapping
dc.titleMapping iron content and white matter integrity in the anterior thalamic radiations across Huntington's disease stages
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
900260.pdf
Mida:
6.7 MB
Format:
Adobe Portable Document Format